Office of Research Message from the Vice Deans of Research Leadership & Staff Clinical Trials Administration Research Support & Development Biostatistical Resources Grant Support & Review Services NIH K and F Submissions Guide Training Grant Support NIH Resubmission Program NIH Resources NIH Boot Camp Physician Scientist Resources Guidance for Proposal Submissions Grant Incentive Programs and Pilot Awards Researcher Pipeline Policies and Guidelines Environmental Health and Safety Human Research Foreign Affiliations School Center Guidelines Space Allocation Vendor Event Policy Responsible Conduct of Research Rigor and Responsibility COVID-19 Response Funding Opportunities School of Medicine Funding Search Tool School of Medicine Funding Search Tool Home Research Office of Research School of Medicine Funding Search Tool Below is a curated, searchable and filterable list of funding opportunities announced by NIH in their weekly NIH guide LISTSERV. This list reflects funding opportunities pertinent to many UCI researchers. Using filters may reduce your results, so use judiciously. Opportunities are added weekly. You can sign up for the NIH guide listserv to receive a comprehensive list of funding opportunities every Friday. NIH Guide Listserv Search Funding Discipline - Any -Acute/Chronic PainAgingAlcoholism, Alcohol UseAlzheimer's/DementiaAmyotrophic lateral sclerosis (ALS)Artificial Intelligence/Machine LearningAutoimmune/ImmunologyBehavioral and Social ScienceBiomedical ImagingBiomedical TechnologyBrain DisordersCancerCancer GenomicsCannabinoid/CannabidiodCardiology/VascularCaregiving ResearchChronic ConditionsClimate ChangeClinical TrialsClinical/DiagnosticCoronaviruses/COVIDData Science/Software/DatabasesDiabetesDigestive/KidneyDissemination and Implementation ResearchDown SyndromeEarly career research awardEating DisordersEmergency CareEnvironmental healthEpilepsyEye Disease and Disorders of VisionFood AllergiesGene TherapyGenetic TestingGynecologyHealth Disparities/Social determinantsHealthcare deliveryHearing LossHematologyHIV/AIDSHuman GenomeHuntington's DiseaseInfectious Diseases/MicrobiologyLung/RespiratoryMedical EducationMental Health/IllnessMicrobiomeMusculoskeletal/SkinN/ANeurology/NeurodegenerativeNutritionObesityOrthopedicOtolaryngology-Head & Neck SurgeryPathologyPatient Care/SafetyPediatricPhysical ActivityPhysical RehabilitationPneumonia & InfluenzaPost-Traumatic Stress Disorder (PTSD)Precision MedicinePregnancy/Maternal Health/ObstetricsRadiation OncologyRare DiseasesRegenerative MedicineSepsisSickle Cell DiseaseSleepSpinal Cord InjuryStem Cell ResearchStrokeSubstance Abuse/AddictionSuicideSurgeryTelehealthTransplantationTraumatic Brain Injury (TBI)UrologyVaccine RelatedVector-Borne DiseasesViolenceWomenWound Healing and Care Date Range Min Max 2024 Deadline 2: Jun 05, 2024 Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) (PAR-23-170) The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations that experience health disparities. National Institutes of Health (NIH) Federal Cancer Caregiving Research Health Disparities/Social determinants 2024 Deadline 2: Jun 05, 2024 Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) (PAR-23-155) This Notice of Funding Opportunity (NOFO) will solicit mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites, and contexts in which expectancy effects can be leveraged to improve cancer outcomes. National Institutes of Health (NIH) Federal Behavioral and Social Science Cancer Healthcare delivery 2024 Deadline 2: Jun 05, 2024 Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) (PAR-23-207) The goal of this Notice of Funding Opportunity (NOFO) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Alzheimer's/Dementia Mental Health/Illness 2024 Deadline 2: Jun 05, 2024 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) (PA-23-189) This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of neural function. For the purposes of this NOFO , the term “complex” can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. National Institutes of Health (NIH) Federal Brain Disorders Neurology/Neurodegenerative 2024 Deadline 2: Jun 05, 2024 PAR-23-254: Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). National Institutes of Health (NIH) Federal Cancer Cancer Genomics Data Science/Software/Databases 2024 Deadline 2: Jun 05, 2024 Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) (PAR-23-245) The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data science approaches that can help individuals understand and improve their health through actionable insights. National Institutes of Health (NIH) Federal Healthcare delivery 2024 Deadline 2: Jun 05, 2024 Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) (PAR-23-264) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate research in discovery and development of novel, small molecules for cancer. Molecules discovered through this NOFO may be used to probe cancer biology, to validate cancer targets, or as the basis for optimized drugs. National Institutes of Health (NIH) Federal Cancer Clinical/Diagnostic 2024 Deadline 2: Jun 05, 2024 Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) (PAR-23-281) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. National Institutes of Health (NIH) Federal Cancer Biomedical Technology 2024 Deadline 2: Jun 05, 2024 NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) (PAR-23-275) The purpose of this notice of funding opportunity (NOFO) is to encourage researchers from diverse backgrounds to work with their institutions to submit applications for research projects within the mission of either NIAID or NIDDK. National Institutes of Health (NIH) Federal Infectious Diseases/Microbiology Digestive/Kidney 2024 Deadline 2: Jun 05, 2024 Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) (PAR-23-302) The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary drawing from the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, modeling, and validation with available large-scale datasets. National Institutes of Health (NIH) Federal Human Genome Pagination First page « First Previous page ‹‹ Page 1 Current page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Next page ›› Last page Last »
2024 Deadline 2: Jun 05, 2024 Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) (PAR-23-170) The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applications to address barriers and facilitators that impede use or uptake of cancer screening and preventive services in populations that experience health disparities. National Institutes of Health (NIH) Federal Cancer Caregiving Research Health Disparities/Social determinants
2024 Deadline 2: Jun 05, 2024 Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) (PAR-23-155) This Notice of Funding Opportunity (NOFO) will solicit mechanistic research that aims to understand how and why expectancy effects occur in a cancer context, elucidate their role in cancer symptom management, and identify patients, symptoms, cancer sites, and contexts in which expectancy effects can be leveraged to improve cancer outcomes. National Institutes of Health (NIH) Federal Behavioral and Social Science Cancer Healthcare delivery
2024 Deadline 2: Jun 05, 2024 Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional) (PAR-23-207) The goal of this Notice of Funding Opportunity (NOFO) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons with Alzheimer's disease (AD) or Alzheimer's disease-related dementias (ADRD). National Institutes of Health (NIH) Federal Neurology/Neurodegenerative Alzheimer's/Dementia Mental Health/Illness
2024 Deadline 2: Jun 05, 2024 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed) (PA-23-189) This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular, and circuit substrates of neural function. For the purposes of this NOFO , the term “complex” can refer to a multifactorial contribution to risk (e.g., polygenic and/or environmental) and/or highly distributed functional features of the brain disorder. National Institutes of Health (NIH) Federal Brain Disorders Neurology/Neurodegenerative
2024 Deadline 2: Jun 05, 2024 PAR-23-254: Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary data analysis and integration of existing datasets and database resources, with the ultimate aim to elucidate cancer risk and related outcomes (e.g., risk prediction or reduction, survival, or response to treatment, etc.). National Institutes of Health (NIH) Federal Cancer Cancer Genomics Data Science/Software/Databases
2024 Deadline 2: Jun 05, 2024 Personal Health Informatics for Delivering Actionable Insights to Individuals (R01 Clinical Trial Optional) (PAR-23-245) The purpose of this Notice of Funding Opportunity (NOFO) is to advance the development of novel informatics and data science approaches that can help individuals understand and improve their health through actionable insights. National Institutes of Health (NIH) Federal Healthcare delivery
2024 Deadline 2: Jun 05, 2024 Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) (PAR-23-264) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate research in discovery and development of novel, small molecules for cancer. Molecules discovered through this NOFO may be used to probe cancer biology, to validate cancer targets, or as the basis for optimized drugs. National Institutes of Health (NIH) Federal Cancer Clinical/Diagnostic
2024 Deadline 2: Jun 05, 2024 Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) (PAR-23-281) Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for projects to expand, improve, or transform the utility of mammalian cancer and tumor models for translational research. National Institutes of Health (NIH) Federal Cancer Biomedical Technology
2024 Deadline 2: Jun 05, 2024 NIAID and NIDDK Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) (PAR-23-275) The purpose of this notice of funding opportunity (NOFO) is to encourage researchers from diverse backgrounds to work with their institutions to submit applications for research projects within the mission of either NIAID or NIDDK. National Institutes of Health (NIH) Federal Infectious Diseases/Microbiology Digestive/Kidney
2024 Deadline 2: Jun 05, 2024 Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) (PAR-23-302) The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary drawing from the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, modeling, and validation with available large-scale datasets. National Institutes of Health (NIH) Federal Human Genome